Novartis To Buy Endocyte In $2.1B Deal (NASDAQ:ECYT)(NYSE:NVS)

Share
Novartis To Buy Endocyte In $2.1B Deal (NASDAQ:ECYT)(NYSE:NVS)

Novartis AG agreed to buy cancer drugmaker Endocyte for $2.1 billion, or $24 a share, expanding further into the increasingly competitive and lucrative field of oncology.

That is a great result for Endocyte-its shares rose 50%. The transaction was unanimously approved by the board of directors of Endocyte, but it is still subject to Endocyte stockholder and regulatory approvals.

Novartis will pay $24 a share for Endocyte, 54% more than its closing price Wednesday of $15.56, the Basel-based company said Thursday.

Until the deal is finalised, Endocyte will continue to operate as a separate and independent company.

"Net sales revised upwards, expected to grow mid-single digit (cc); core operating income guidance confirmed, expected to grow mid to high-single digit (cc)", Novartis said in its earnings release.

Novartis said that, after completing the deal, it will harness its research and expertise to investigate the development of Endocyte's 177Lu-PSMA-617, a radioligand therapy for the treatment of metastatic castration-resistant prostate cancer.

The company's products in pre-clinical development include EC2629, a folate receptor-targeted SMDC for use in treating cancer; EC2319 for the treatment of inflammatory diseases; EC0371 for treating polycystic kidney disease; and SMDC bi-specific adaptor chimeric antigen receptor T-cell for the treatment of immunotherapy in cancer.

Since taking over in February, Narasimhan has shed over-the-counter medicines and generic pills while pushing a spinoff of Novartis's Alcon eyecare unit come 2019.

The acquisition of Endocyte builds on Novartis' January 2018 $3.9-billion purchase of Advanced Accelerator Applications, through which the company gained Lutathera, a peptide receptor radionuclide therapy that has gained European and the US approval for the treatment of somatostatin-receptor positive gastroenteropancreatic neuroendocrine tumors.

The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents.

Stocks in a West Lafayette drug development company are soaring Thursday.

Share

Advertisement

Related Posts

Five myths about the Flu with Dr. Marshall Dawer
During the 2017-2018 influenza ( flu) season (October to May), more than 700,000 Americans were hospitalized. However, if you are not able to get a flu shot at that date and time, you can contact Wagener for a flu shot.

Facebook Gets Former UK Deputy PM Nick Clegg for Global Policy
He will move to California in the New Year alongside his wife, Dechert lawyer Miriam Gonzalez-Durantez, and their three sons. After intense "wooing" the former deputy prime minister has become its head of global affairs and communications.

OnePlus 6T will be unveiled a day early thanks to Apple
The OnePlus 6T is expected to bring plenty of innovations to this mid-range device including an in-screen fingerprint scanner. This means the release of the OnePlus 6T will now take place on October 29 at 11am rather than the original October 30 date.

Netflix Posts Big Rebound in Subscriber Growth
Netflix's report was the first from one of the big technology companies that helped drive the S&P 500 to a record last month. The rising yield contagion eventually made its way to the stock market, hurting several tech giants like Netflix .

Mega Millions winning numbers announced for $420 million jackpot
There was no Mega Millions jackpot victor Friday night, sending the prize soaring to $470 million for the next drawing . The lump-sum payment for the Powerball jackpot is $148.4 million or winners can choose 30 annual installments.

Mexico says 2 buses arrive at border crossing
And he threatened to send troops to "shut down" the southern USA border if Mexico failed to stop what he called an "onslaught". NBC News reports the Mexican government sent 500 officers to the country's border with Guatemala ahead of their approach.

Eden Hazard reassures Chelsea FC supporters about his future plans
Hazard has been at Stamford Bridge since 2012, when he joined from Lille, and made himself a fan favourite. I love the fans - I think the fans love me. "Leaving or staying, I knew I was going to be happy.

Amazon announces sponsorship ahead of the Invictus Games in Sydney
Prince Harry will then take his trip to Sydney to new heights by climbing the Sydney Harbour Bridge. And now Prince Harry can tick climbing the Sydney Harbour Bridge off his bucket list, too.

Listen To The Otherworldly Sounds Made By An Antarctic Ice Sheet
But if we deployed seismic sensors on more ice shelfs, you could observe subtle environmental changes, in minutes. Each collapse allows ice to flow even faster, raising sea levels to unsafe new heights.

Dodgers don't want to waste any time dispatching Brewers
The American League champion Red Sox await in the World Series. "We're trying to get to the World Series", Miley said. For the 31-year-old Miley, the back-to-back starts are another highlight in a turnaround season with Milwaukee .

© 2015 ExpressNewsline. All Rights reserved.